Genome Editing, Ethics, and Politics.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1105, doi. 10.1001/amajethics.2019.1105
- By:
- Publication type:
- Article
Works matching IS 23766980 AND DT 2019 AND VI 21 AND IP 12
Results: 15
1
2
Sunset.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1103, doi. 10.1001/amajethics.2019.1103
- By:
- Publication type:
- Article
3
What Does Multiple Production of Artworks Teach Us About Authenticity and Germline Editing?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1098, doi. 10.1001/amajethics.2019.1098
- By:
- Publication type:
- Article
4
What Should Clinicians Do to Engage the Public About Gene Editing?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1089, doi. 10.1001/amajethics.2019.1089
- By:
- Publication type:
- Article
5
Prioritizing Women's Health in Germline Editing Research.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1074, doi. 10.1001/amajethics.2019.1071
- By:
- Publication type:
- Article
6
Why Include the Public in Genome Editing Governance Deliberation?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1065, doi. 10.1001/amajethics.2019.1065
- By:
- Publication type:
- Article
7
How Should Gene Editing Be Managed by Risk Managers?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1059, doi. 10.1001/amajethics.2019.1059
- By:
- Publication type:
- Article
8
AMA Policies and Code of Medical Ethics' Opinions Related to Human Genome Editing.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1056, doi. 10.1001/amajethics.2019.1056
- By:
- Publication type:
- Article
9
An Exclusive Interview With CRISPR.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1079, doi. 10.1001/amajethics.2019.1079
- By:
- Publication type:
- Article
10
Is Gene Editing Patentable?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1049, doi. 10.1001/amajethics.2019.1049
- By:
- Publication type:
- Article
11
What Is Prudent Governance of Human Genome Editing?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1042, doi. 10.1001/amajethics.2019.1042
- By:
- Publication type:
- Article
12
Using the 4-S Framework to Guide Conversations With Patients About CRISPR.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1029, doi. 10.1001/amajethics.2019.1029
- By:
- Publication type:
- Article
13
How Should "CRISPRed" Babies Be Monitored Over Their Life Course to Promote Health Equity?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1036, doi. 10.1001/amajethics.2019.1036
- By:
- Publication type:
- Article
14
How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions?
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1021, doi. 10.1001/amajethics.2019.1021
- By:
- Publication type:
- Article
15
Ethics, Values, and Responsibility in Human Genome Editing.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 12, p. 1017, doi. 10.1001/amajethics.2019.1017
- By:
- Publication type:
- Article